Education
About Us
Working with TipRanks
Follow Us
GeneDx Holdings (WGS)
NASDAQ:WGS
Earnings Data
Report Date
Nov 17, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.39Last Year’s EPS
0.04Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive sentiment with significant revenue growth, record high margins, and successful integration into new markets like NICU. However, challenges remain in expanding into the general pediatrics market and gaining broader payer coverage.Company Guidance
Record Revenue Achievement
GeneDx achieved over $100 million in revenue for the first time in a single quarter, with second quarter revenues of $102.7 million, a 49% increase year-over-year.
Exome and Genome Revenue Surge
Revenue from exome and genome testing reached a record high of $85.9 million, up 69% from the same quarter last year.
Strong Gross Margin
The company expanded its adjusted gross margin to a record high of 71%, driven by a favorable mix shift, improved reimbursement, and lower costs.
Pediatric Neurologist Market Success
Pediatric neurologists made up a majority of new ordering providers, capturing nearly 1/3 of the target clinicians in this segment.
NICU Market Opportunity
The NICU represents a $1 billion market opportunity, with 42 out of 50 top NICUs having ordered testing from GeneDx this year.
Guidance Increase
Raised full-year revenue guidance to between $400 million and $415 million, with an expectation of at least 30% year-over-year volume growth.
WGS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
WGS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 29, 2025 | $84.91 | $91.78 | +8.09% |
Apr 30, 2025 | $116.97 | $66.85 | -42.85% |
Feb 18, 2025 | $76.35 | $112.76 | +47.69% |
Oct 29, 2024 | $56.06 | $84.02 | +49.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does GeneDx Holdings (WGS) report earnings?
GeneDx Holdings (WGS) is schdueled to report earning on Nov 17, 2025, After Close (Confirmed).
What is GeneDx Holdings (WGS) earnings time?
GeneDx Holdings (WGS) earnings time is at Nov 17, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WGS EPS forecast?
WGS EPS forecast for the fiscal quarter 2025 (Q3) is 0.39.